BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells
David Debruyne(Boston Children's Hospital), Rani E. George(Harvard University)
Cited by 142
Related Papers
ALK inhibitor resistance in ALKF1174L-driven neuroblastoma is associated with AXL activation and induction of EMT
|Oncogene|2015|125
Cell lineage as a predictor of immune response in neuroblastoma
|bioRxiv (Cold Spring Harbor Laboratory)|2021|8
The MYCN 5′ UTR as a therapeutic target in neuroblastoma
|Cell Reports|2024|5